Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Stem Cell Transplantation in Iran: A Systematic Review Article



Abbasi R1 ; Larijani B2 ; Nasli Esfahani E1 ; Ghorbani M3 ; Rambod C1 ; Heshmat R4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Community Medicine, Alborz University of Medical Sciences, Karaj, Iran
  4. 4. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Public Health Published:2015

Abstract

Background: Stem cell therapy is a new treatment option for different diseases. The aim of this systematic review is assessing the articles that focus on SCT in Iran and evaluate the amount of their success, failure and complication. Methods: Systematic search was conducted for finding English and Persian papers (controlled trials and cohort studies with follow up) published before March 2015. We searched PubMed, ISI, and SCOPUS as the main international electronic data sources, as well as Iranmedex, Irandoc, and SID as the main domestic databases. Quality assessment of clinical trial and cohort study was performed based on the Consolidated Standards of Reporting Trials (CONSORT) and the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) check lists respectively. Results: The 19 published articles in this systematic review included 2 cohort, 13 clinical trial, 3 open label clinical trial and 1 clinical trial pilot study. The stem cell types for transplantation were Mesenchymal (63.15%), mononuclear (31.6%), and fetal liver cell suspension (5.6%). The most SCT was performed at Tehran (68.42%), Shiraz (15.8%), Kerman & Isfahan hospitals (5.26%). The main diseases were decompensated cirrhosis and myocardial infarction (26.31%), MS (15.78%), DM (10.52%), Burger disease, neuroblastoma, sub-acute spinal cord injury and osteoarthritis (5.26%). Conclusion: The most of cells transplantation are performed successfully in Iran. Cell transplantation may be safely administered to treat patients with disabling disease. © 2015, Tehran University of Medical Sciences. All rights reserved.
Related Docs
View other Related Docs
1. Ankylosing Spondylitis and Mesenchymal Stromal/Stem Cell Therapy: A New Therapeutic Approach, Biomedicine and Pharmacotherapy (2019)
2. Intraportal Infusion of Bone Marrow Mononuclear or Cd133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial, Stem Cells Translational Medicine (2016)
3. Clinical Cell Therapy Guidelines for Neurorestoration (Ianr/Canr 2017), Cell Transplantation (2018)
4. Stem Cell Therapy ‒Approach for Multiple Sclerosis Treatment, Archives of Neuroscience (2016)
5. Novel Cell-Based Therapies in Hepatic Disorders, Journal of Mazandaran University of Medical Sciences (2020)
6. Cell and Cell-Derivative-Based Therapy for Liver Diseases: Current Approaches and Future Promises, Expert Review of Gastroenterology and Hepatology (2023)
7. Investigating the Safety and Efficacy of Hematopoietic and Mesenchymal Stem Cell Transplantation for Treatment of T1dm: A Systematic Review and Meta-Analysis, Systematic Reviews (2022)
8. Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases, Handbook of Stem Cell Applications (2024)
Experts (# of related papers)
View all Related Experts
Bagher Larijani (7)
Hamidreza Aghayan (5)
Other Related Docs
9. Assessment of Immune-Alternations and Their Correlations With Therapeutic Outcomes of Transplantation of Autologous Mesenchymal and Allogenic Fetal Stem Cells in Patients With Type 1 Diabetes: A Study Protocol, Journal of Diabetes and Metabolic Disorders (2021)
10. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
11. Immunomodulatory Characteristics of Mesenchymal Stem Cells and Their Role in the Treatment of Multiple Sclerosis, Cellular Immunology (2015)
12. Mesenchymal Stem Cells for Multiple Sclerosis (Mesems): A Randomized, Double Blind, Cross-Over Phase I/Ii Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis, Trials (2019)
13. Stem Cell-Based Approach for the Treatment of Parkinson's Disease, Medical Journal of the Islamic Republic of Iran (2015)
14. The Effect of Fetal Liver-Derived Cell Suspension Allotransplan-Tation on Patients With Wolfram Syndrome: The First Year of Fol-Low-Up, Iranian Journal of Public Health (2015)
15. Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination With Pioglitazone in Patients With Compensated Cirrhosis: A Clinical Report of Two Cases, Archives of Iranian Medicine (2016)
16. The Effect of Bone Marrow-Derived Mesenchymal Stem Cell Co-Transplantation With Hematopoietic Stem Cells on Liver Fibrosis Alleviation and Survival in Patients With Class Iii Β-Thalassemia Major, Stem Cell Research and Therapy (2021)
17. Application of Fetal Stem Cells in Diabetes: Iran’S Experience, Iranian Journal of Public Health (2015)
18. Insulin Independence After Fetal Liver-Derived Cell Suspension Allotransplantation in Patients With Type 1 Diabetes: A Pilot Study, Iranian Journal of Public Health (2015)
19. Therapeutic Use of Intrathecal Mesenchymal Stem Cells in Patients With Multiple Sclerosis: A Pilot Study With Booster Injection, Immunological Investigations (2019)
20. Multipotent Stem Cell and Current Application, Acta Medica Iranica (2017)
21. Shining the Light on Clinical Application of Mesenchymal Stem Cell Therapy in Autoimmune Diseases, Stem Cell Research and Therapy (2022)
22. Mechanisms and Potentials of Stem Cells in the Treatment of Multiple Sclerosis: The Unpaved Path, Multiple Sclerosis: A Mechanistic View (2016)
23. Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations, Medical Journal of the Islamic Republic of Iran (2022)